← Back to your news feed
Health & Life SciencesResearch paperSource analysis

AI sped pulmonary-embolism triage at one German hospital—but did patients benefit?

A retrospective before-and-after study linked an AI-supported response-team workflow to faster diagnosis and treatment, but reductions in hospital stay and 30-day mortality were not statistically significant.

By The Impact of AI Editorial DeskReleased 22 October 2026 at 17:00 BST4 min full report · 2 min summary1 source · view evidence
Share
Social links
LinkedInXBlueskyRedditEmail

The short version

What happened
Researchers retrospectively screened 2,500 presentations with symptomatic central or segmental pulmonary embolism at University Hospital Essen; 424 patients met the study's inclusion criteria.
Who it affects
For a person with a dangerous clot, faster coordination could shorten the wait between imaging and a specialist decision. The present evidence cannot yet say that this reduces death, complications or time in hospital.
What remains unproven
This was a retrospective before-and-after study at one German university hospital, not a randomised or contemporaneously controlled trial. Secular changes, staffing and greater use of the response team could explain part of the association.

Keep in mind

This was a retrospective before-and-after study at one German university hospital, not a randomised or contemporaneously controlled trial. Secular changes, staffing and greater use of the response team could explain part of the association.

Only 424 of 2,500 screened presentations met the inclusion criteria. The accessible abstract does not provide the pre/post group sizes, baseline balance, false-alert rate or algorithm performance.

Hospital stay, intensive-care stay and 30-day mortality did not improve significantly. The cost result came from an exploratory model and is not evidence of realised savings.

The journal page exposed the peer-reviewed accepted-manuscript abstract but gated the full PDF at review time. Funding and conflict declarations were therefore not verifiable from the accessible record and should be checked when the final article appears.

Source analysis · 1 linked source. Primary analysed source date: 22 October 2026.

Keep following the evidence

Join The Impact Brief founding list for selected AI reports, their effect on people and the evidence limits. Read a sample first.

Three AI findings, one useful evidence visual and links to the full reporting. See a sample. Our weekly briefing is prepared on Fridays; unsubscribe at any time.

Choose your topics (optional)

A welcome email follows signup. Unsubscribe at any time.

Read the full report · 4 min The evidence, methods, implications and limitations

The clearest result is a faster pathway, not a clinical cure

A peer-reviewed study published on 22 October reports what happened after one German university hospital added an algorithm to its pulmonary-embolism pathway. The software analysed CT scans, flagged suspected clots in the lungs and supported triage by the hospital's pulmonary embolism response team, or PERT. These multidisciplinary teams decide quickly whether a patient needs treatment beyond anticoagulant medicine.

The researchers retrospectively screened 2,500 people who presented with symptomatic central or segmental pulmonary embolism from August 2022 to July 2024. A total of 424 met the study's inclusion criteria. Outcomes in the one-year period before implementation were compared with those in the year after it; the accessible abstract does not report the number in each period.[1]

Team activation and treatment intervals changed sharply

PERT activation increased from 9.2% before implementation to 84.5% afterwards. The time between completing a CT scan and recording the pulmonary-embolism diagnosis fell from 2.1 hours to 1.3 hours. Among patients receiving an intervention, the interval from diagnosis to treatment was halved. The reported statistical tests supported all three process differences.

Those numbers matter because high-risk pulmonary embolism can deteriorate rapidly. A reliable alert may help the right clinicians assemble sooner and reduce time spent waiting between scan, diagnosis and a treatment decision. But the intervention was a package: an algorithm, an alert and a team workflow. This design cannot isolate how much of the change came from the model rather than more consistent PERT use, staff learning or other changes over time.[1]

The distinction that matters

What changed—and what the study did not establish

The intervention linked image analysis to a human response team. The strongest evidence concerns the speed and consistency of that pathway.

CT scan

Algorithm flags a suspected pulmonary embolism

Earlier case visibility

PERT triage

Multidisciplinary team reviews the flagged patient

Activation rose from 9.2% to 84.5%

Patient outcomes

Compare stays and 30-day mortality before and after

No statistically significant improvement established

This is a process diagram, not a claim that every flag caused a faster or better outcome. Percentages and time intervals come from the study's retrospective before-and-after comparison. Source: European Heart Journal – Digital Health

The outcomes patients feel most remained uncertain

Hospital and intensive-care stays and 30-day mortality moved in a favourable direction, but none of those differences reached statistical significance. That does not show the workflow had no benefit; it means this cohort did not establish one. A model-based budget analysis also suggested lower per-patient costs and annual savings, mainly from reduced resource use. It was exploratory rather than an observed financial result.

The next evidential step is a prospective, adequately powered comparison across several hospitals. It should prespecify patient outcomes, separate alert performance from team activation, report false alerts and missed cases, and measure whether any savings actually occur. Until then, the study supports a promising way to organise urgent care—not a claim that AI itself saves lives or hospital budgets.[1]

National Cancer Institute researcher Chanelle Case Borden preparing genetic samples for PCR.

Illustrative photo · not a video frame

The Royal Society · 44 min 28 sec · Background explainer

Is this the AI future we want? | The Royal Society

YouTube loads only when you choose; playback starts when you press play.

A Royal Society discussion with Madhumita Murgia and biomedical engineer Alison Noble on AI’s potential in healthcare, science and culture, recorded at the 30 June 2026 event.

Evidence check: A discussion of opportunities and risks, including future possibilities. It is not evidence that every application described is available or clinically proven.

Published 2026-07-01. Source checked 14 October 2026. Check captions on the publisher’s video page.

Check the healthcare evidence

Photo: Daniel Sone / National Cancer Institute / Unsplash · Licence

Share
Social links
LinkedInXBlueskyRedditEmail

Continue the story

Read next

All reports
Explore the full source and evidence record

What this means for people

  • For a person with a dangerous clot, faster coordination could shorten the wait between imaging and a specialist decision. The present evidence cannot yet say that this reduces death, complications or time in hospital.

Global context

Pulmonary-embolism response teams and radiology staffing differ between hospitals. A workflow that succeeds in a specialist German centre may not transfer to smaller hospitals or systems without an established multidisciplinary team.

What the evidence does not yet show

  • This was a retrospective before-and-after study at one German university hospital, not a randomised or contemporaneously controlled trial. Secular changes, staffing and greater use of the response team could explain part of the association.
  • Only 424 of 2,500 screened presentations met the inclusion criteria. The accessible abstract does not provide the pre/post group sizes, baseline balance, false-alert rate or algorithm performance.
  • Hospital stay, intensive-care stay and 30-day mortality did not improve significantly. The cost result came from an exploratory model and is not evidence of realised savings.
  • The journal page exposed the peer-reviewed accepted-manuscript abstract but gated the full PDF at review time. Funding and conflict declarations were therefore not verifiable from the accessible record and should be checked when the final article appears.

What to watch next

  • Prospective multicentre comparisons with a concurrent control group
  • Patient-centred outcomes powered to detect meaningful differences
  • False alerts, missed clots and clinician workload
  • Observed costs rather than modelled budget estimates
  • The final article's funding and conflict declarations

Living evidence record

Impact record IAI-1P87KHB

Explore the full tracker

Evidence stage

Studied

Confidence

Supported

Reporting basis

Source analysis

Independent or research support

Present

Record status

Monitoring

Last checked

22 October 2026

Source trail

1 direct source across 1 source type.

People impact

Documented in this record.

Uncertainty

Limits and next checks are explicit.

Stages describe the evidence available—not whether a technology is good or bad. See the public method.

Single-source reporting disclosure

This record analyses one direct source. It can establish what European Heart Journal – Digital Health published or reported, but it is not independent corroboration of every performance claim or predicted outcome. The confidence label will change only when broader evidence is added.

Evidence trail

Sources used for this report

Links checked 22 October 2026

Research question, topics and regions

Whether an AI-supported pulmonary embolism response-team workflow changed care processes, resource use or patient outcomes after implementation

Topics: Pulmonary embolism · Clinical AI · Emergency care · Radiology · Workflow evidence

Regions: Germany · Europe

This report is labelled source analysis. We summarise and analyse source material in our own words; company statements remain attributed claims until independently supported. Translated summaries preserve the meaning of the original source and link back to it. Read our editorial standards.

Reader commentary

What does this mean where you are?

Tell us what you have seen at work, in your community or in everyday life. A question is welcome too. No account is needed; we review notes before publishing them.

Explore commentary across the portal →

Do not include personal, confidential or unlawful information.

Published reader notes

0

No published reader notes yet. You can start the evidence-led discussion above.

Prefer a private correction or response? Contact the newsroom.